title: ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
authors.affiliation: Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, United Kingdom.
authors.forename: Susanne A
authors.initials: SA
authors.lastname: Schneider
authors.forename: Coro
authors.initials: C
authors.lastname: Paisan-Ruiz
authors.forename: Niall P
authors.initials: NP
authors.lastname: Quinn
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Lees
authors.forename: Henry
authors.initials: H
authors.lastname: Houlden
authors.forename: John
authors.initials: J
authors.lastname: Hardy
authors.forename: Kailash P
authors.initials: KP
authors.lastname: Bhatia
mesh_terms: D000328:Adult; D001921:Brain / Q000378:metabolism*; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009154:Mutation / Q000235:genetics*; D009410:Nerve Degeneration / Q000209:etiology / Q000235:genetics / Q000473:pathology; D006180:Proton-Translocating ATPases / Q000235:genetics*
chemical_list: C514983:ATP13A2 protein, human; D007501:Iron; D006180:Proton-Translocating ATPases